Labshake search
Citations for R&D Systems :
201 - 250 of 1359 citations for SARS CoV 2 Spike E M Mosaic Protein His tag E. coli since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2023Quote: ... rhKGF (10 ng/m; “K”; R&D Systems), 50 nM dexamethasone (“D” ...
-
bioRxiv - Neuroscience 2024Quote: ... 25 ng/mL M-CSF (R&D System) and 50 ng/mL TGFβ1 (STEMCELL Technologies ...
-
bioRxiv - Microbiology 2024Quote: ... and 50ng/ml M-CSF (R&D Systems) to induce macrophage differentiation ...
-
bioRxiv - Immunology 2021Quote: ... Recombinant human His-tagged CD80 (R&D Systems 9050-B1, Minneapolis, MN, USA) or CD86 (R&D Systems 9090-B2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and recombinant human TIM-4-HIS (R&D Systems, Cat# 9407-TM-050)) ...
-
bioRxiv - Cell Biology 2022Quote: ... washed with PBS and incubated with recombinant Jagged 1 protein (JAG1, 2 µg/ml, R&D System) for 3 h at room temperature ...
-
bioRxiv - Immunology 2022Quote: ... Recombinant Human IL-27 Ra/WSX-1/TCCR Fc Chimera Protein (2 μg/ml, R&D Systems), Ultrapure LPS from E ...
-
bioRxiv - Cancer Biology 2019Quote: ... Membranes were then probed with anti-FLAG tag (1:2000, R&D Systems), anti-pVHL (1:500 ...
-
bioRxiv - Immunology 2023Quote: ... and 100 ng/mL anti-HA tag antibody (clone 543851, R&D Systems) to PBMC medium and incubating for 15 min at room temperature to crosslink the proteins ...
-
bioRxiv - Synthetic Biology 2024Quote: ... 2.5 µL anti-hEGF tag antibody (Anti-hEGF-biotin, R&D Systems BAF236) was added at a concentration of 0.5 µg per sample and cells incubated at 4 °C for 20 min ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 20 ng/ml M-CSF (R&D Systems).
-
bioRxiv - Immunology 2021Quote: ... 40ng/ml of rm M-CSF (R&D System) and allowed to differentiate for 7 days.
-
bioRxiv - Microbiology 2022Quote: ... plus 10 ng/mL M-CSF (R&D Systems). Fully differentiated MDMs were maintained in media containing RPMI 1640 plus 10% dialyzed FBS ...
-
bioRxiv - Microbiology 2023Quote: ... and 10 ng/mL M-CSF (R&D Systems). On Day 2 and Day 4 ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... and anti-M-CSF (#AF416 from R&D Systems). Detection was performed using peroxidase-coupled secondary antibody ...
-
bioRxiv - Molecular Biology 2023Quote: ... and 25 ng/mL M-CSF (R&D Systems) for 2 days ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... 20 ng/mL oncostatin M (R&D Systems, 295OM050), and 0.1 μM dexamethasone (Millipore Sigma ...
-
bioRxiv - Cancer Biology 2022Quote: For recombinant E6 proteins and sdAbs: 2 µg of E6 (R&D Systems Inc., Cat. # AP-120-025), MBP (Abnova ...
-
bioRxiv - Pathology 2024Quote: ... Cell surface protein expression was performed by labeling 2×105 cells for KDR-PE (R&D Systems, FAB357P) + PDGFRα-APC (Cell Signaling ...
-
bioRxiv - Biophysics 2024Quote: ... Purified kinetochores were incubated with biotinylated α-His antibody (R&D Systems, Minneapolis MN) at an antibody concentration of 0.025 ng/µl for 1 hour at 4 °C with rotation ...
-
bioRxiv - Microbiology 2020Quote: ... + 50 ng/ml M-CSF (R&D Systems, https://www.rndsystems.com) and 50 ng/ml GM-CSF + 500 U/ml IL-4 (Biolegend ...
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... and 30ng/ml M-CSF (R&D Systems, Abingdon, UK) and incubated in T75 flasks for 24h at 37°C ...
-
bioRxiv - Cell Biology 2022Quote: ... 40 ng/mL M-CSF (R&D Systems, 416-ML). The cells were then incubated with osteoclastogenesis medium ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml M-IL4 (R&D systems, 404-ML-050) and 20ng/ml M-IL13 (R&D systems ...
-
bioRxiv - Immunology 2020Quote: ... containing 20 ng/mL M-CSF (R&D System, USA) on 10-cm petri dishes and renewed the medium every other day ...
-
bioRxiv - Pathology 2022Quote: ... and 25 ng/mL M-CSF (R&D Systems, USA). The medium was changed every three days until the BMMs reached 95% confluency ...
-
bioRxiv - Cancer Biology 2023Quote: ... TNFα (5 ng/m; R&D systems #210-TA-020) and IFNγ (25 IU/mL ...
-
bioRxiv - Cell Biology 2024Quote: ... and 20ng/mL M-CSF (R&D Systems: 416-ML) at 37°C and 5% CO2 ...
-
bioRxiv - Molecular Biology 2024Quote: ... Recombinant mouse M-CSF was obtained from R&D Systems. miRNeasy mini kit (cat# 1038703) ...
-
bioRxiv - Microbiology 2020Quote: ... Approximately 5000 RU of Recombinant Human Desmoglein-2 Fc Chimera Protein (R&D Systems, Catalogue number 947-DM-100) was amine coupled to a CM5 sensor chip at a slow flow-rate of 10 μl/min to ensure uniform distribution on the chip surface.
-
bioRxiv - Synthetic Biology 2021Quote: ... and Alexa Fluor 647® (AF647)-conjugated anti-His antibody (R&D Systems, catalog # IC0501R) or HER2-ED (R&D Systems ...
-
bioRxiv - Microbiology 2021Quote: ... and 20 ng/ml of M-CSF (R&D System, USA). The coculture of BMMs with MSCs was done using a transwell system (0.4 µm pore size ...
-
bioRxiv - Cell Biology 2021Quote: ... monocyte colony stimulating factor (M-CSF, 20ng/mL, R&D Systems). EOC2 cultures were maintained in DMEM media supplemented with 10% HI FBS ...
-
bioRxiv - Biochemistry 2021Quote: ... and 20 ng/ml M-CSF (R&D Systems; #416-ML) and plated into 6-well tissue culture plates ...
-
bioRxiv - Neuroscience 2021Quote: ... and 20ng/ml M-IL13 (R&D systems, 413-ML-005). BMDM were used in experiments after 1week of differentiation.
-
bioRxiv - Immunology 2023Quote: ... and M-CSF by the ELISA kit from R&D Systems; Multiplex suspension array (IL-4 ...
-
bioRxiv - Bioengineering 2023Quote: ... with 20 ng/mL human recombinant Oncostatin M (R&D Systems). On differentiation day 25 ...
-
bioRxiv - Cell Biology 2024Quote: ... human recombinant macrophage-colony stimulating factor (M-CSF, R&D Systems), Lysoview-633 (biotium) ...
-
bioRxiv - Neuroscience 2020Quote: Primary antibodies for immunoprecipitation and Western blotting included anti-V5 and anti-His (R&D systems), Mouse anti-VAMP2 (SySy Synaptic Systems ...
-
bioRxiv - Cell Biology 2019Quote: Reagents were obtained as follows: M-CSF (R&D Systems, Abingdon, UK), RANKL (Peprotech ...
-
bioRxiv - Physiology 2021Quote: ... and 30ng/mL recombinant mouse M-CSF (R&D systems, Minneapolis, MN). Fresh medium was replenished every 3 days ...
-
bioRxiv - Physiology 2021Quote: ... and 30ng/mL recombinant mouse M-CSF (R&D systems, Minneapolis, MN). Fresh medium was replenished every 3 days.
-
bioRxiv - Immunology 2019Quote: ... carrier-free M-CSF (50 ng/ml, R&D Systems, Minneapolis, Minnesota) and GM-CSF (50 ng/ml ...
-
bioRxiv - Immunology 2021Quote: ... or M-CSF (25 ng/mL, 216-MC-025, R&D Systems) in the presence or absence of purified β-glucan from Candida albicans (10 μg/mL unless otherwise stated ...
-
bioRxiv - Immunology 2021Quote: ... in the presence of M-CSF (50 ng/mL, R&D Systems) and GM-CSF (50 ng/mL ...
-
bioRxiv - Molecular Biology 2023Quote: ... (VEGF, Mouse, ELISA Kit, Quantikine M, MMV00, R&D Systems, Minneapolis, MN), tPA (Mouse tPA ELISA Kit ...
-
bioRxiv - Biophysics 2024Quote: ... were functionalized with biotinylated α-penta-His antibody (Qiagen, Hilden Germany or R&D Systems, Minneapolis MN) and stored in BRB80 containing 8 mg/ml BSA and 1 mM DTT at 4 °C with continuous rotation ...
-
bioRxiv - Cell Biology 2020Quote: Relative phosphorylation levels of 43 kinases and 2 related proteins were assessed using the Proteome Profiler Human Phospho-Kinase Array Kit (R&D Systems), according to the manufacturer’s instructions ...
-
bioRxiv - Neuroscience 2022Quote: ... VEGFR-1 and VEGFR-2 protein levels were quantified with the DuoSet® ELISA Development System Kit (R&D Systems, Abingdon, UK), according to manufacturer instructions ...
-
bioRxiv - Bioengineering 2021Quote: Recombinant human IDO expressed in Escherichia coli was purchased from R&D Systems (Minneapolis, MN) with a predicted molecular mass of 46 kDa a specific activity of >500pmoles/min/μg (or for equimolar calculations >29 pmol NFK/min/pmol IDO ...